Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study
- 25 August 2008
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 48 (3), 243-252
- https://doi.org/10.1002/mc.20475
Abstract
Deregulation of insulin‐like growth factor (IGF)‐I/IGF‐IR signaling has been implicated in the development and progression of prostate cancer. Agents that can suppress the mitogenic activity of the IGF/IGF‐IR growth axis may be of preventive or therapeutic value. We have previously demonstrated that apigenin, a plant flavone, modulates IGF signaling through upregulation of IGFBP‐3. In this study, we investigated the mechanism(s) of apigenin action on the IGF/IGF‐IR signaling pathway. Exposure of human prostate cancer DU145 cells to apigenin markedly reduced IGF‐I‐stimulated cell proliferation and induced apoptosis. Apigenin inhibited IGF‐I‐induced activation of IGF‐IR and Akt in DU145 cells. Similar growth inhibitory and apoptotic responses were observed in PC‐3 cells, which constitutively overexpress this pathway. This effect of apigenin appears to be due partially to reduced autophosphorylation of IGF‐IR. Inhibition of p‐Akt by apigenin resulted in decreased phosphorylation of GSK‐3β along with decreased expression of cyclin D1 and increased expression of p27/kip1. In vivo administration of apigenin to PC‐3 tumor xenografts inhibited tumor growth, resulted in IGF‐IR inactivation and dephosphorylation of Akt and its downstream signaling. These results suggest that inhibition of cell proliferation and induction of apoptosis by apigenin are mediated, at least in part, by its ability to inhibit IGF/IGF‐IR signaling and the PI3K/Akt pathway.Keywords
This publication has 52 references indexed in Scilit:
- Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenograftsBreast Cancer Research, 2007
- Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cellsToxicology and Applied Pharmacology, 2007
- Insulin Receptor Substrate Is a Mediator of Phosphoinositide 3-Kinase Activation in Quiescent Pancreatic Cancer CellsCancer Research, 2005
- Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude miceThe FASEB Journal, 2005
- Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung CancerMolecular Pharmacology, 2005
- Unbalanced activation of ERK1/2 and MEK1/2 in apigenin-induced HeLa cell deathExperimental Cell Research, 2004
- Selective Growth-Inhibitory, Cell-Cycle Deregulatory and Apoptotic Response of Apigenin in Normal versus Human Prostate Carcinoma CellsBiochemical and Biophysical Research Communications, 2001
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Regulation of DUI45 human prostate cancer cell proliferation by insulin‐like growth factors and its interaction with the epidermal growth factor autocrine loopThe Prostate, 1994